Back
Full-text
Journal article

Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

  • Anderson AC Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Joller N Institute of Experimental Immunology, University of Zürich, Zürich 8057, Switzerland.
  • Kuchroo VK Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: vkuchroo@evergrande.hms.harvard.edu.
  • 2016-05-19
Published in:
  • Immunity. - 2016
Animals
Antigens, CD
CTLA-4 Antigen
Hepatitis A Virus Cellular Receptor 2
Humans
Immune Tolerance
Lymphocyte Activation
Programmed Cell Death 1 Receptor
Receptor Cross-Talk
Receptors, Immunologic
Signal Transduction
T-Lymphocytes
English Co-inhibitory receptors, such as CTLA-4 and PD-1, have an important role in regulating T cell responses and have proven to be effective targets in the setting of chronic diseases where constitutive co-inhibitory receptor expression on T cells dampens effector T cell responses. Unfortunately, many patients still fail to respond to therapies that target CTLA-4 and PD-1. The next wave of co-inhibitory receptor targets that are being explored in clinical trials include Lag-3, Tim-3, and TIGIT. These receptors, although they belong to the same class of receptors as PD-1 and CTLA-4, exhibit unique functions, especially at tissue sites where they regulate distinct aspects of immunity. Increased understanding of the specialized functions of these receptors will inform the rational application of therapies that target these receptors to the clinic.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/166196
Statistics
Document views: 7 File downloads:
  • fulltext.pdf: 0